StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.33−0.53 (-7.73%)

Close on Nov 20, 2026Market cap $573.27MP/E –Yield –

Verastem gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Verastem's gross profit for the twelve months ending Dec 31, 2018 was $26.55M. For fiscal 2018 it was $26.55M.

Annual gross profit

PeriodPeriod endValueChange
FY2018Dec 31, 2018$26.55M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$47.46M–
Q1 FY2019Mar 31, 2019$1.51M–
Q4 FY2018Dec 31, 2018$1.09M–
Q3 FY2018Sep 30, 2018$15.46M–

More Verastem figures

See a number that looks wrong?